Immunological mechanisms of pentoxifylline in chronic heart failure

European Journal of Heart Failure

Volumn 11, Issue 7, 2009, Pages 728-

  Silverberg, Donald S ^a   Wexler, Dov ^a   Iaina, Adrian ^a   Schwartz, Doron ^a  

^a TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIANEMIC AGENT; ERYTHROPOIETIN; HEMOGLOBIN; IRON; PENTOXIFYLLINE; BIOLOGICAL MARKER; IMMUNOLOGIC FACTOR; VASODILATOR AGENT;

ANEMIA; CLINICAL TRIAL; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEMODIALYSIS; HUMAN; KIDNEY FAILURE; LETTER; PRIORITY JOURNAL; BLOOD; CHRONIC DISEASE; DRUG EFFECTS; HEART LEFT VENTRICLE FUNCTION; HEART STROKE VOLUME; IMMUNOLOGY; METABOLISM;

ANEMIA; BIOLOGICAL MARKERS; CHRONIC DISEASE; HEART FAILURE; HEMOGLOBINS; HUMANS; IMMUNOLOGIC FACTORS; PENTOXIFYLLINE; STROKE VOLUME; VASODILATOR AGENTS; VENTRICULAR FUNCTION, LEFT;

EID: 67650074762     PISSN: 13889842     EISSN: 18790844     Source Type: Journal    
DOI: 10.1093/eurjhf/hfp067     Document Type: Letter

References (5)

1. Shaw SM, Shaw MKH, Williams SG, Fildes JE. Immunological mechanisms of pentoxifylline in chronic heart failure. Eur J Heart Fail 2009; 11:113-118.
2. Cooper A, Mikhail A, Lethbridge MW, Kemeny DM, Macdougall IC. Pentoxifylline improves hemoglobin levels with erythropoietin-resistant anemia in renal failure. J Am Soc Nephrol 2004; 15:1877-1882.
3. Navarro JF, Mora C, Garcia J et al Effects of pentoxifylline on the haematologic status in anaemic patients with advanced renal failure. Scand J Urol Nephrol 1999; 33:121-125.
4. Lainscak M, Anker SD, von Haehling S, Ponikowski P, Libhaber C, Sliwa K. Pentoxifylline increases hemoglobin in patients with chronic heart failure. Eur Heart J 2007; 28(Abstract Supplement):52.
5. Silverberg DS, Wexler D, laina A, Schwartz D. The role of anaemia in patients with congestive heart failure: a short review. Eur J Heart Fail 2008; 10:819-823.